US20150289981A1 - Orthopaedic polymer-on-polymer bearings - Google Patents

Orthopaedic polymer-on-polymer bearings Download PDF

Info

Publication number
US20150289981A1
US20150289981A1 US14/438,672 US201314438672A US2015289981A1 US 20150289981 A1 US20150289981 A1 US 20150289981A1 US 201314438672 A US201314438672 A US 201314438672A US 2015289981 A1 US2015289981 A1 US 2015289981A1
Authority
US
United States
Prior art keywords
joint
polymer
joint according
barium sulphate
polyaryletherketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/438,672
Inventor
Adam Briscoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invibio Ltd
Original Assignee
Invibio Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invibio Ltd filed Critical Invibio Ltd
Publication of US20150289981A1 publication Critical patent/US20150289981A1/en
Assigned to INVIBIO LIMITED reassignment INVIBIO LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRISCOE, Adam
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/16Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28Materials for coating prostheses
    • A61L27/30Inorganic materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/446Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2/30942Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques
    • A61F2002/30957Designing or manufacturing processes for designing or making customized prostheses, e.g. using templates, CT or NMR scans, finite-element analysis or CAD-CAM techniques using a positive or a negative model, e.g. moulds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0076Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/24Materials or treatment for tissue regeneration for joint reconstruction

Abstract

The invention is a prosthetic joint, for example knee joint, including a first joint component which is preferably polyetheretherketone containing barium sulphate and a second joint component which is preferably a polyolefin.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a US National Stage Application that claims the benefit of prior filed, co-pending, PCT application number PCT/GB2013/052770 filed on Oct. 24, 2013. Both this application and the aforementioned PCT application also claim priority to GB Application 1219686.1 filed on Nov. 1, 2012. Both the PCT application PCT/GB2013/052770 and the GB application 1219686.1 are herein incorporated by reference in their entireties.
  • TECHNICAL FIELD AND BACKGROUND OF THE INVENTION
  • This invention refers to orthopaedic polymer-on-polymer bearings and particularly, although not exclusively, relates to bearings comprising a hard part, for example a polyaryletherketone part bearing on a softer part, for example a polyethylene part.
  • US 2010/0312348 (Howmedica Osteonics) describes an orthopaedic prosthesis joint comprising a joint couple having a first bearing surface made of a polyaryletherketone (PAEK) and a second joint component having a second bearing surface made of a material which is softer than the PAEK, the first and second bearing surfaces being in sliding engagement with one another. Polyethylene is exemplified as the preferred second bearing surface.
  • The PAEK, or more specifically the polyetheretherketone (PEEK) exemplified, is unfilled and in the example PEEK heads made are polished, presumably to reduce their roughness with the aim of reducing abrasion when the PEEK slides over the polyethylene thereby to reduce wear on the polyethylene.
  • However, a problem exists with the prosthetic joint in that it is difficult to visualise the joint under X-rays and, accordingly, it is difficult to fully assess the joint when implanted in the human body.
  • Prior to the present invention, it was thought to be undesirable to include fillers in the harder PAEK part. Such fillers would increase roughness (Ra) of the harder part and/or protrude from the surface. If the filler was significantly harder than the PAEK part or the material of the counterface of the second joint component, there would be a risk of severe abrasion and/or wear on the softer counterface in use. For example, observations on a hard part comprising PEEK containing carbon fibre, bearing against a softer polyethylene counterface, show the detrimental effect of adding the carbon fibre filler—wear on the polyethylene part increases significantly. This is described in the examples which follow. Thus, prior to the present invention, the problem of improving visualisation of a joint of the type described under X-rays had not been solved.
  • SUMMARY OF THE INVENTION
  • It is an object of the present invention to improve visualisation of a prosthetic joint under X-rays.
  • It is an object of the present invention to solve the stated problem without a significant detrimental effect on wear.
  • According to a second aspect of the invention, there is provided an orthopaedic prosthetic joint having a joint couple. The joint couple may include a first joint component having a first bearing surface made of a first polymer; and a second joint component having a second bearing surface made of a second polymer. According to such an aspect of the invention: the first and second bearing surfaces are in sliding engagement with one another; the first bearing surface is made of a first material which is harder than a second material from which the second joint surface is made; and the first material comprise a polyaryletherketone and barium sulphate.
  • The orthopaedic prosthetic joint of the first and/or second aspects may be as described further below.
  • Said barium sulphate may have a D10 particle size in the range 0.1 to 1.0 μm; a D50 particle size suitably in the range 0.5 μm to 2 μm and a D90 particle size suitably in the range 1.0 μm to 5 μm. The D10 may be in the range 0.1 to 0.6 μm, preferably 0.2 to 0.5 μm. The D50 may be in the range 0.7 μm to 1.5 μm, preferably 0.8 to 1.3 μm. The D90 may be in the range 1.5 to 3 μm, preferably in the range 2.0 to 2.5 μm.
  • Unless otherwise stated, particle sizes may be assessed by laser diffraction, suitably in accordance with ISO13320.
  • The ratio of the wt % of barium sulphate to the wt % of said first polymer may be greater than 0.04, is suitably greater than 0.07, is preferably greater than 0.10, is more preferably greater than 0.13, and is especially greater than 0.16. In some cases, said ratio may be greater than 0.20 or 0.22. The ratio may be less than 0.4, or less than 0.3.
  • Said barium sulphate is preferably intimately mixed with the first polymer, suitably so the barium sulphate and first polymer define a substantially homogenous mixture. Said first material preferably comprises a said homogenous mixture.
  • Said first bearing surface (for example said first material) may include at least 1 wt %, suitably at least 2 wt %, preferably at least 3 wt % barium sulphate. The amount of barium sulphate may be 30 wt % or less, 20 wt % or less, for example 15 wt % or less. Said first bearing surface (for example said first material) may include 2 to 10 wt %, for example 3 to 8 wt % barium sulphate.
  • The ratio comprising the wt % of said first polymer divided by the wt % of said barium sulphate in said bearing surface (for example in said first material) is suitably in the range 5 to 25, preferably in the range 9 to 18.
  • Said first material preferably includes less than 5 wt % of fibres, for example less than 2 wt % or less than 0.5 wt %. It preferably includes no fibres.
  • A preferred polyaryletherketone has a repeat unit of formula (I)
  • Figure US20150289981A1-20151015-C00001
  • where t1 and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2.
  • Said polyaryletherketone suitably includes at least 90, 95 or 99 mol % of repeat unit of formula I.
  • Said polyaryletherketone preferably consists essentially of a repeat unit of formula I. Preferred polymeric materials comprise (especially consist essentially of) a said repeat unit wherein t1=1, v1=0 and w1=0; t1=0, v1=0 and w1=0; t1=0, w1=1, v1=2; or t1=0, v1=1 and w1=0. More preferred comprise (especially consist essentially of) a said repeat unit wherein t1=1, v1=0 and w1=0; or t1=0, v1=0 and w1=0. The most preferred comprises (especially consists essentially of) a said repeat unit wherein t1=1, v1=0 and w1=0.
  • In preferred embodiments, said polymeric material is selected from polyetheretherketone, polyetherketone, polyetherketoneetherketoneketone and polyetherketoneketone. In a more preferred embodiment, said polymeric material is selected from polyetherketone and polyetheretherketone. In an especially preferred embodiment, said polymeric material is polyetheretherketone.
  • Said polyaryletherketone may have a Notched Izod Impact Strength (specimen 80 mm×10 mm×4 mm with a cut 0.25 mm notch (Type A), tested at 23° C., in accordance with ISO180) of at least 4 KJm−2, preferably at least 5 KJm−2, more preferably at least 6 KJm−2. Said Notched Izod Impact Strength, measured as aforesaid, may be less than 10 KJm−2, suitably less than 8 KJm−2. The Notched Izod Impact Strength, measured as aforesaid, may be at least 3 KJm−2, suitably at least 4 KJm−2, preferably at least 5 KJm−2. Said impact strength may be less than 50 KJm−2, suitably less than 30 KJm−2.
  • Said polyaryletherketone suitably has a melt viscosity (MV) of at least 0.06 kNsm−2, preferably has a MV of at least 0.09 kNsm−2, more preferably at least 0.12 kNsm−2, especially at least 0.15 kNsm−2. Advantageously, the MV may be at least 0.35 kNsm−2 and especially at least 0.40 kNsm−2. An MV of 0.45 kNsm−2 has been found to be particularly advantageous in the manufacture of accurate, strong frameworks.
  • MV is suitably measured using capillary rheometry operating at 400° C. at a shear rate of 1000 s−1 using a tungsten carbide die, 0.5 mm×3.175 mm.
  • Said polyaryletherketone may have a MV of less than 1.00 kNsm−2, preferably less than 0.5 kNsm−2.
  • Said polyaryletherketone may have a MV in the range 0.09 to 0.5 kNsm−2, preferably in the range 0.14 to 0.5 kNsm−2, more preferably in the range 0.4 to 0.5 kNsm−2.
  • Said polyaryletherketone may have a tensile strength, measured in accordance with ISO527 (specimen type 1b) tested at 23° C. at a rate of 50 mm/minute of at least 20 MPa, preferably at least 60 MPa, more preferably at least 80 MPa. The tensile strength is preferably in the range 80-110 MPa, more preferably in the range 80-100 MPa.
  • Said polyaryletherketone may have a flexural strength, measured in accordance with ISO178 (80 mm×10 mm×4 mm specimen, tested in three-point-bend at 23° C. at a rate of 2 mm/minute) of at least 50 MPa, preferably at least 100 MPa, more preferably at least 145 MPa. The flexural strength is preferably in the range 145-180 MPa, more preferably in the range 145-164 MPa.
  • Said polyaryletherketone may have a flexural modulus, measured in accordance with ISO178 (80 mm×10 mm×4 mm specimen, tested in three-point-bend at 23° C. at a rate of 2 mm/minute) of at least 1 GPa, suitably at least 2 GPa, preferably at least 3 GPa, more preferably at least 3.5 GPa. The flexural modulus is preferably in the range 3.5-4.5 GPa, more preferably in the range 3.5-4.1 GPa.
  • Said polyaryletherketone may be amorphous or semi-crystalline. It is preferably crystallisable. It is preferably semi-crystalline.
  • The level and extent of crystallinity in a polymer is preferably measured by wide angle X-ray diffraction (also referred to as Wide Angle X-ray Scattering or WAXS), for example as described by Blundell and Osborn (Polymer 24, 953, 1983). Alternatively, crystallinity may be assessed by Differential Scanning calorimetry (DSC).
  • The level of crystallinity of said polyaryletherketone may be at least 1%, suitably at least 3%, preferably at least 5% and more preferably at least 10%. In especially preferred embodiments, the crystallinity may be greater than 25%. It may be less than 50% or less than 40%.
  • The main peak of the melting endotherm (Tm) of said polyaryletherketone (if crystalline) may be at least 300° C.
  • Said second material may be selected from a polyethylene, a polyurethane, a polyamide and a composite of these polymers. It preferably comprises polyethylene.
  • Said second material preferably comprises at least 60 wt %, more preferably at least 75 wt %, especially at least 90 wt % of the polymeric material selected from polyethylene, a polyurethane and polyamide. Said second material preferably includes a single type of polymeric material.
  • Said second material preferably includes at least 90 wt %, more preferably at least 96 wt %, especially at least 99 wt % of polyethylene. The balance may comprise additives and/or fillers, for example an anti-oxidant such as Vitamin C.
  • Said polyethylene may be crosslinked. It is preferably crosslinked, for example by irradiation. It may comprise UHMWPE. Preferably, it comprises UHMWPE which has been crosslinked at least three times by irradiation. It may comprise X3™ UHMWPE of Stryker Corporation, crosslinked as described in U.S. Pat. No. 7,517,919.
  • Said first bearing surface may be defined by a coating of said first polymer on another body for example a solid body. Preferably, however, said first bearing surface does not comprise a coating. Preferably, said first joint component comprises a self-supporting body made from said first polymer wherein said body incorporates said first bearing surface, suitable as an integral part thereof. Preferably, at least 80 wt % of said first joint component is made up of said first polymer; the balance may be said barium sulphate. Preferably, the sum of the wt % of said first polymer (especially polyetheretherketone) and barium sulphate in said first joint component is at least 90 wt %, preferably at least 95 wt %, more preferably at least 99 wt %. Preferably, said first joint component consists essentially of polyetheretherketone and barium sulphate.
  • Said first joint component may include at least 0.5 g, preferably at least 1 g, more preferably at least 5 g of said first polymer. Said first joint component may include less than 1 kg of said first polymer.
  • Said first joint component may have a weight of at least 1 g, preferably at least 5 g. The weight may be less than 1 kg.
  • Said second bearing surface may be defined by a coating of said second polymer on another body for example a solid body. Preferably, however, said second bearing surface does not comprise a coating. Preferably, said second joint component comprises a self-supporting body made from said second polymer wherein said body incorporates said second bearing surface, suitably as an integral part thereof. Suitably, at least 80 wt % preferably at least 90 wt %, more preferably at least 95 wt %, especially at least 99 wt % of said second joint component is made up of said second polymer.
  • Said second joint component may include at least 0.5 g, preferably at least 1 g, more preferably at least 5 g of said second polymer. Said second joint component may include less than 1 kg of said second polymer. Said second joint component may include less than 1 kg of said second polymer. Said bearing surface of said second joint component may include 0.5 g, preferably at least 1 g, more preferably at least 5 g of said second polymer.
  • Said second joint component may have a weight of at least 1 g, preferably at least 5 g. The weight may be less than 1 kg.
  • In the prosthetic joint, said first and second joint components may be movable relative to one another. For example, a bearing surface of one of the components may be arranged to slide over a bearing surface of the other component. Said first and second bearing components may be pivotable relative to one another.
  • Preferably the entire area of the first bearing surface which area contacts the second bearing surface comprises said first material; and the entire area of said second bearing surface which area contacts the first bearing surface comprises said second material.
  • Said orthopaedic prosthetic joint may be selected from the group consisting of a hip joint, knee joint, spine joint, shoulder joint, elbow joint, tow joint, finger joint and ankle joint.
  • Said orthopaedic prosthetic joint is preferably a knee joint. The femoral component may comprise said first material; and the tibial component may comprise the second material.
  • According to a third aspect, there is provided a method of making an orthopaedic prosthetic joint as described in the first and/or second aspects, the method comprising a moulding (e.g. injection moulding) step and optional machining step to make the first joint component; and a moulding (e.g. injection moulding) step and optional machining step to make the second joint component.
  • According to a fourth aspect of the invention, there is provided the use of a first joint component as described according to the first and/or second aspects and a second joint component as described according to the first and/or second aspects in the manufacture of an orthopaedic prosthetic joint which comprises said first and second joint components bearing against one another for implantation into the human body, for example to replace a structural element of the body.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • For a better understanding of the invention, and to show how embodiments of the same may be carried into effect, reference will now be made, by way of example, to the accompanying diagrammatic drawings in which:
  • FIG. 1 shows the Volumetric Wear Rate in units of mm3/MC.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS AND BEST MODE
  • Any feature of any aspect of the invention or embodiment described herein may be combined with any other feature of any aspect of an invention or embodiment described herein mutatis mutandis.
  • Specific embodiments of the invention will now be described by way of example, with reference to FIG. 1 which is a graph showing volumetric wear rates for a series of samples.
  • The following materials are referred to hereinafter:
  • PEEK-OPTIMA (Trade Mark)—Long term implantable grade polyetheretherketone with a melt viscosity of approximately 0.45 kNsm−2, obtainable from Invibio Limited, UK;
  • GUR 1020 E (Trade Mark)—ultra-high molecular weight polyethylene containing Vitamin E obtained from Ticona;
  • GUR 1020 (Trade Mark)—as previous but not containing Vitamin E;
  • MOTIS (Trade Mark)—polyetheretherketone containing carbon fibres obtainable from Invibio Ltd, UK;
  • Barium sulphate—Barium sulphate grade 10175 from Merck.
  • Pin-on-disc testing was undertaken to assess various combinations of materials as described below.
  • Examples 1 to 8 Manufacture of Pins and Discs
  • Materials to be tested were machined into discs and pins as applicable. As manufactured, the pins had a diameter of 9 mm and length of 12 mm; the articulating end of the pins was machined flat. The discs were 10 mm thick, with the upper articulating surface of diameter 24.8 mm, with a circumferential groove to accommodate an o-ring to seal the chamber onto the disc. Prior to the start of the test, the discs and pins were soaked in deionized water for 56 days to allow for fluid uptake to reach equilibrium. The compositions of the discs and pins are detailed in Table 1.
  • TABLE 1
    Example No. Composition Test Specimen
    1 PEEK-OPTIMA LT-1 with 6 wt % Disc
    barium sulphate dispersed
    2 PEEK-OPTIMA LT-1 with 6 wt % Pin
    barium sulphate dispersed
    3 GUR 1020 E Pin
    4 GUR 1020 E Disc
    5 PEEK OPTIMA LT-1 Disc
    6 MOTIS Disc
    7 GUR 1020 Pin
    8 PEEK-OPTIMA LT-1 Pin
  • Example 9 Testing Equipment and Method
  • A T87 multi-station Pin-on-Disc machine (SuperPOD) was used, available from Phoenix Tricology, UK. The discs were mounted in a test bath on top of a motion module. Water was circulated through the test bath at 37±3° C. A lubricant chamber (volume 15 ml) was mounted around each disc, so that each station had an independent volume of bovine serum lubricant. Each test pin was mounted on a carrier rod, restrained against rotation, with each pin independently loaded by means of a pneumatic piston. Air was supplied to the pistons from a common plenum chamber, resulting in constant air pressure applied to each piston, so each pin had an equal load applied. The load applied to each pin was 128 N, giving a nominal pressure of 2.01 MPa (pin diameter 9 mm).
  • The lubricant was Thermo Scientific Hyclone Wear Testing Fluid (Bovine serum) with 20 g/l total protein concentration. An antibiotic and fungicide were each added at a concentration of 1.5% to reduce the deterioration of the test fluid due to fungal and bacterial action during each 0.25 MC interval. At the end of each interval, the test fluid for each material combination was collected and frozen.
  • In the T87 SuperPOD, the pins were stationary and the discs followed an elliptical path without any rotation. The motion module was mounted on X and Y linear bearings and actuated through a double scotch yoke mechanism. The amplitude was 5 mm (stroke 10 mm) in the X direction and the amplitude was 2.5 mm (stroke 5 mm) in the Y direction. This gave a total path length of 24.2 mm per cycle. Throughout the test, the frequency of motion was 1 Hz. The motion of the SuperPOD meant the pins were subjected to full cross shear, but the discs were only subjected to cross shear in the limited zone in the middle of the “worn area” where the wear track crossed itself during the cycle.
  • For each combination of materials referred to, five specimens were tested in wear stations on the SuperPOD and one as a load soak control. The load soak was maintained under the same load as the wear specimens in an identical solution of bovine serum, but was not subjected to the sliding motion. The discs and pins were randomly assigned to the material pairing and either to a load soak or wear station. The location of the five stations testing each material pair was randomly distributed throughout the 100 stations on SuperPOD.
  • Every 0.25 MC the wear test was stopped for interval analysis and the test specimens removed for characterisation. At each interval, the lubricant was collected from each of the five wear stations for each material combination and frozen for potential future particle analysis. The pins and discs were cleaned and dried using the procedure described in ASTM F1714 “Standard Guide for Gravimetric Wear Assessment of Prosthetic Hip Designs in Simulator Devices”. The o-rings, chambers and pin holders were subjected to the same cleaning process but were not dried. Photographs were taken of the pins and discs at each interval analysis.
  • The samples were weighed three times in rotation using a Sartorius balance (Bohemia, N.Y.). During each interval analysis, the load soak was dried and weighed and used to compensate for the fluid uptake of the specimens in the wear stations. The increase in mass of the load soak due to fluid uptake was added to the reduction in mass of each sample to give a corrected wear.
  • The gravimetric wear loss was converted to a volumetric wear loss using the material densities.
  • The wear factor was calculated for each material couple and was intended to allow comparisons between wear tests using different loads and sliding distance. The wear factor was derived from the Archard Wear Equation, which is based on the principle that the wear volume is proportional to the product of the sliding distance and real area of contact.
  • The wear factor k was calculated by:
  • k = V W × L
  • where V is the volumetric wear (mm3/), W is the normal load (N) and L the sliding distance (m).
  • The units are mm3/Nm.
  • Examples 10-16
  • A series of wear couples were tested as detailed in Table 2 and volumetric wear rates established. Results are summarized in FIG. 1. For each wear couple the wear rate for the pin is shown on the left and that for the disc is shown on the right.
  • TABLE 2
    Example No. Pin Material Disc Material
    10 3 1
    11 7 6
    12 3 6
    13 7 5
    14 3 5
    15 2 4
    16 8 4

    The following should be noted from FIG. 1.
      • (a) Example 13 relates to a combination of PEEK and ultra-light molecular weight polyethylene. The example can be compared to Example 11 which shows a combination of carbon fibre filled PEEK bearing against the same polyethylene. The comparison illustrates the effect on the wear of the polyethylene in adding filler into the PEEK—wear on the polyethylene increases significantly.
      • (b) Example 14 may be compared with Example 12 as described in (a) above and the same conclusions drawn.
      • (c) Example 10 includes a disc which comprises PEEK and barium sulphate bearing against a pin which comprises a polyethylene. This may be compared to Example 14 which is the same combination except that the disc comprises pure PEEK with no barium sulphate. In contrast to the effect of filler discussed in (a) and (b), it will be noted that the wear on the polyethylene for both Examples 10 and 14 are similar, meaning the addition of barium sulphate has had surprisingly little effect on wear.
      • (d) Example 15 includes a pin which comprises PEEK and barium sulphate bearing against a disc which comprises polyethylene. This may be compared to Example 16 which is the same combination except that the pin comprises pure PEEK with no barium sulphate. Thus, as described in (c), it should be appreciated that the comparison surprisingly shows addition of barium sulphate has little effect on wear.
  • This, it should be appreciated that barium sulphate can be added to PEEK for one part of a bearing component, at a level sufficient to give image contrast, with surprisingly little effect on wear of an associated polyethylene bearing component in use.
  • The invention is not restricted to the details of the foregoing embodiment(s). The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.

Claims (25)

What is claimed is:
1. An orthopaedic prosthetic joint comprising a joint couple comprising:
(a) a first joint component having a first bearing surface comprising a first material which comprises a first polymer;
(b) a second joint component having a second bearing surface comprising a second material which comprises a second polymer;
wherein said first and second bearing surfaces are in sliding engagement with one another;
wherein said first polymer is harder than said second polymer;
wherein said first material includes barium sulphate.
2. A joint according to claim 1, wherein said first material is a polyacetal or a polyaryletherketone and said second material is a polyolefin, a polyurethane or a polyamide.
3. An orthopaedic prosthetic joint comprising a joint couple comprising:
(a) a first joint component having a first bearing surface made of a first polymer; and
(b) a second joint component having a second bearing surface made of a second polymer;
wherein said first and second bearing surfaces are in sliding engagement with one another;
wherein said first bearing surface is made of a first material which is harder than a second material from which the second joint surface is made;
wherein said first material comprise a polyaryletherketone and barium sulphate.
4. A joint according to claim 1, wherein said barium sulphate has a D10 particle size in the range 0.1 to 1.0 μm.
5. A joint according to claim 1, wherein the ratio of the wt % of barium sulphate to the wt % of said first polymer is greater than 0.04 and is less than 0.4.
6. A joint according to claim 1, wherein said first bearing surface includes at least 1 wt % barium sulphate and includes 30 wt % or less of barium sulphate.
7. A joint according to claim 1, wherein said polyaryletherketone has a repeat unit of formula (I)
Figure US20150289981A1-20151015-C00002
where t1 and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2.
8. A joint according to claim 1, wherein said polyaryletherketone has a melt viscosity (MV) of at least 0.35 kNsm−2.
9. A joint according to claim 1, wherein said polyaryletherketone has a crystallinity of greater than 25%.
10. A joint according to claim 1, wherein said second material is selected from a polyethylene, a polyurethane, a polyamide and a composite of these polymers.
11. A joint according to claim 1, wherein said first joint component consists essentially of polyetheretherketone and barium sulphate; and at least 80 wt % of said second joint component is made up of said second polymer.
12. A joint according to claim 1, wherein said second material comprises at least 60 wt % of a polymeric material selected from polyethylene, a polyurethane and a polyamide.
13. A joint according to claim 12, wherein said second material comprises a polyethylene.
14. A joint according to claim 1, which is a knee joint.
15. A method of making an orthopaedic prosthetic joint according to any preceding claim, the method comprising a moulding step and optional machining step to make the first joint component; and a moulding step and optional machining step to make the second joint component.
16. The use of a first joint component according to claim 1, and a second joint component in the manufacture of an orthopaedic prosthetic joint which comprises said first and second joint components bearing against one another for implantation into the human body, for example to replace a structural element of the body.
17. A joint according to claim 3, wherein said barium sulphate has a D10 particle size in the range 0.1 to 1.0 μm.
18. A joint according to claim 3, wherein the ratio of the wt % of barium sulphate to the wt % of said first polymer is greater than 0.04 and is less than 0.4.
19. A joint according to claim 3, wherein said first bearing surface includes at least 1 wt % barium sulphate and includes 30 wt % or less of barium sulphate.
20. A joint according to claim 3, wherein said polyaryletherketone has a repeat unit of formula (I)
Figure US20150289981A1-20151015-C00003
where t1 and w1 independently represent 0 or 1 and v1 represents 0, 1 or 2.
21. A joint according to claim 3, wherein said polyaryletherketone has a melt viscosity (MV) of at least 0.35 kNsm−2.
22. A joint according to claim 3, wherein said polyaryletherketone has a crystallinity of greater than 25%.
23. A joint according to claim 3, wherein said second material is selected from a polyethylene, a polyurethane, a polyamide and a composite of these polymers.
24. A joint according to claim 3, wherein said first joint component consists essentially of polyetheretherketone and barium sulphate; and at least 80 wt % of said second joint component is made up of said second polymer.
25. A joint according to claim 3, wherein said second material comprises at least 60 wt % of a polymeric material selected from polyethylene, a polyurethane and a polyamide.
US14/438,672 2012-11-01 2013-10-24 Orthopaedic polymer-on-polymer bearings Abandoned US20150289981A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1219686.1 2012-11-01
GBGB1219686.1A GB201219686D0 (en) 2012-11-01 2012-11-01 Orthopaedic polymer-on-polymer bearings
PCT/GB2013/052770 WO2014068285A1 (en) 2012-11-01 2013-10-24 Orthopaedic polymer-on-polymer bearings

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2013/052770 A-371-Of-International WO2014068285A1 (en) 2012-11-01 2013-10-24 Orthopaedic polymer-on-polymer bearings

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/538,130 Continuation US11103352B2 (en) 2012-11-01 2019-08-12 Orthopaedic polymer-on-polymer bearings

Publications (1)

Publication Number Publication Date
US20150289981A1 true US20150289981A1 (en) 2015-10-15

Family

ID=47359018

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/438,672 Abandoned US20150289981A1 (en) 2012-11-01 2013-10-24 Orthopaedic polymer-on-polymer bearings
US16/538,130 Active 2033-12-20 US11103352B2 (en) 2012-11-01 2019-08-12 Orthopaedic polymer-on-polymer bearings

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/538,130 Active 2033-12-20 US11103352B2 (en) 2012-11-01 2019-08-12 Orthopaedic polymer-on-polymer bearings

Country Status (3)

Country Link
US (2) US20150289981A1 (en)
GB (2) GB201219686D0 (en)
WO (1) WO2014068285A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11179243B2 (en) 2007-02-28 2021-11-23 Happe Spine Llc Implantable devices
US20080206297A1 (en) 2007-02-28 2008-08-28 Roeder Ryan K Porous composite biomaterials and related methods
CN105030376B (en) * 2015-02-10 2017-02-01 江苏奥康尼医疗科技发展有限公司 Total hip surface replacement implant
CN113811266A (en) 2019-03-12 2021-12-17 哈佩脊椎有限责任公司 Implantable medical device having a thermoplastic composite and method for forming a thermoplastic composite
JP2023501531A (en) 2019-11-12 2023-01-18 デピュイ・アイルランド・アンリミテッド・カンパニー Composite orthopedic prosthesis and method of making same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20070270691A1 (en) * 2006-05-19 2007-11-22 Bailey Michael L Radiopaque compositions, articles and methods of making and using same
US20090276051A1 (en) * 2008-05-05 2009-11-05 Spinalmotion, Inc. Polyaryletherketone Artificial Intervertebral Disc

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2429930C (en) 2002-06-06 2008-10-14 Howmedica Osteonics Corp. Sequentially cross-linked polyethylene
WO2007016795A1 (en) * 2005-08-09 2007-02-15 Dr.H.C. Robert Mathys Stiftung Device for the artificial replacement of a joint articulation in humans and animals
GB0604061D0 (en) * 2006-03-01 2006-04-12 Invibio Ltd Polymetric materials
GB2469991B (en) * 2009-04-21 2013-08-07 Invibio Ltd Polymeric materials
CA2706233C (en) * 2009-06-04 2015-05-05 Howmedica Osteonics Corp. Orthopedic peek-on-polymer bearings

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228900B1 (en) * 1996-07-09 2001-05-08 The Orthopaedic Hospital And University Of Southern California Crosslinking of polyethylene for low wear using radiation and thermal treatments
US20070270691A1 (en) * 2006-05-19 2007-11-22 Bailey Michael L Radiopaque compositions, articles and methods of making and using same
US20090276051A1 (en) * 2008-05-05 2009-11-05 Spinalmotion, Inc. Polyaryletherketone Artificial Intervertebral Disc

Also Published As

Publication number Publication date
GB2510014A (en) 2014-07-23
GB201318797D0 (en) 2013-12-11
US11103352B2 (en) 2021-08-31
GB2510014B (en) 2018-02-14
US20190358040A1 (en) 2019-11-28
GB201219686D0 (en) 2012-12-12
WO2014068285A1 (en) 2014-05-08

Similar Documents

Publication Publication Date Title
US11103352B2 (en) Orthopaedic polymer-on-polymer bearings
AU2007220362B2 (en) Assembly comprising composite materials for bearing surfaces and uses thereof in reconstructive or artificial joints
AU2002245513B2 (en) Cross-linked ultra-high molecular weight polyethylene for use as medical implant
JP5732044B2 (en) Polymer materials containing barium sulfate
Baleani et al. Fatigue strength of PMMA bone cement mixed with gentamicin and barium sulphate vs pure PMMA
Wannomae et al. Delamination and Adhesive Wear Behavior of α-Tocopherol–Stabilized Irradiated Ultrahigh-Molecular-Weight Polyethylene
CN101998974A (en) Ultra high molecular weight polyethylene for bearing surfaces
EP1839685B1 (en) Bearing material for a medical implant
EP1882483B1 (en) Medical implant bearing material
Saikko A hip wear simulator with 100 test stations
Brandt et al. Wear testing of crosslinked polyethylene: Wear rate variability and microbial contamination
Kyomoto et al. Multidirectional wear and impact-to-wear tests of phospholipid-polymer-grafted and vitamin E-blended crosslinked polyethylene: a pilot study
Good et al. Wear of ultra-high molecular weight polyethylene and polytetrafluoroethylene in a hip simulator: a dose-response study of protein concentration
US20100076114A1 (en) Polymeric materials
US20090326673A1 (en) Polymeric material
US9700651B2 (en) Bearing material and method of producing the same
Tozzi et al. The effects of contact area and applied load on the morphology of in vitro worn ultra‐high molecular weight knee prostheses: a micro‐Raman and gravimetric study
JP6061670B2 (en) Method for manufacturing sliding member for artificial joint and sliding member for artificial joint
Affatato et al. In vitro wear assessments of fixed and mobile UHMWPE total knee replacement
RU2729653C1 (en) High strength antifriction composite based on polyetheretherketone for medicine and method of its production
US8858979B1 (en) Service induced byproducts for localized drug delivery in orthopaedic implants
Mulliez et al. In vitro wear performance of X-ray cross-linked vitamin E blended polyethylene
Das et al. Wear Performance of UHMWPE and PCU Artificial Disc Materials
EP2858689A1 (en) Polyether urethane and polyether urea based copolymers and methods related thereto
Sitton et al. Residue analysis on RPVOT test samples for single and multiple antioxidants chemistry for turbine lubricants

Legal Events

Date Code Title Description
AS Assignment

Owner name: INVIBIO LIMITED, GREAT BRITAIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BRISCOE, ADAM;REEL/FRAME:036992/0576

Effective date: 20150520

STCV Information on status: appeal procedure

Free format text: ON APPEAL -- AWAITING DECISION BY THE BOARD OF APPEALS

STCV Information on status: appeal procedure

Free format text: BOARD OF APPEALS DECISION RENDERED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION